Literature DB >> 8323737

Porcine membranoproliferative glomerulonephritis with intramembranous dense deposits (porcine dense deposit disease).

J H Jansen1.   

Abstract

A membranoproliferative glomerulonephritis (MPGN) was diagnosed in 10 Yorkshire piglets, aged between 33 and 73 days, that had been submitted for routine autopsy. Matings of animals related to these piglets subsequently produced 15 offspring that had a membranoproliferative glomerulonephritis when examined at between 5 and 48 days of age. The principal light microscopic changes in all examined glomeruli of all affected piglets were thickening of the glomerular capillary walls and a conspicuous mesangial cell proliferation. The glomerular capillary walls of the affected piglets possessed a weak but distinct autofluorescence when stained with thioflavine T and a strong reactivity for complement factor 3 as demonstrated with immunohistochemical techniques. Ultrastructural examination revealed intramembranous dense deposits in the glomerular basement membranes of kidneys from all affected piglets. On the basis of the initial matings and the morphological observations, it is concluded that the described MPGN in Yorkshire piglets represents an inherited renal disease that is comparable to human MPGN type II-dense deposit disease.

Entities:  

Mesh:

Year:  1993        PMID: 8323737     DOI: 10.1111/j.1699-0463.1993.tb00112.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

Authors:  Guido A Hegasy; Tamara Manuelian; Kolbjorn Hogasen; Johan H Jansen; Peter F Zipfel
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Systemic necrotizing vasculitis and glomerulonephritis in grower pigs in southwestern Quebec.

Authors:  P Hélie; R Drolet; M C Germain; A Bourgault
Journal:  Can Vet J       Date:  1995-03       Impact factor: 1.008

3.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 5.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

6.  Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.

Authors:  Xiaoxu Wang; Menno Van Lookeren Campagne; Kenneth J Katschke; Damodar Gullipalli; Takashi Miwa; Yoshiyasu Ueda; Yuan Wang; Matthew Palmer; Guolan Xing; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-12       Impact factor: 10.121

7.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 8.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.